NL-OMON23540招募中不适用
Mycophenolate sodium (Myfortic®) in the Treatment of Uveitis: a Pilot Study.
JAM van Laar, ErasmusMC0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
Volgen.
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Eligible patients with uveitis not responding to steroids due to:
- •a. Ocular sarcoidosis;
排除标准
- •1. Inability to visualize the fundus;
- •2. Ocular surgery < 3 months of treatment;
研究者
相似试验
进行中（未招募）
不适用
Mycophenolate sodium (Myfortic®) in the Treatment of Uveitis: a Pilot Study. - Mycophenolate sodium (Myfortic®) in the Treatment of Uveitis: a Pilot Study.EUCTR2006-004709-24-NLErasmusMC
已完成
3 期
Mycophenolate sodium (Myfortic) in the Treatment of Uveitis: a Pilot Study.inflammatory eye disease1002187710027665uveitisNL-OMON30290Academisch Medisch Centrum24
已完成
不适用
Observational study;Mycophenolate sodium (Myfortic) in primary Sjogren’s syndrome.1. Sjogren's syndrome<br />2. Mycophenolate sodium<br />3. Sicca syndrome<br />4. Immunosuppression.NL-OMON28051Professor Dr. Markus GaubitzMuenster University ClinicAlbert Schweitzer Sreet 3348129 Muenster Germanygaubitz@uni-muenster.deTel: +49-251-835756211
Unknown
不适用
Mycophenolate Sodium (Myfortic®) in the Treatment of Corticosteroid-refractory Autoimmune Uveitis:Pilot StudyUveitisNCT01261169Genovate Biotechnology Co., Ltd.,40
已完成
4 期
Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized StudyNephrosis, LipoidNCT01185197The University of Hong Kong20